Prognosis
Hydroxychloroquine Study Published in Lancet Retracted
Hydroxychloroquine at a pharmacy in Provo, Utah, U.S.
Photographer: George Frey/AFP via Getty Images
This article is for subscribers only.
NOTE TO READERS: The authors of the study have retracted the work this May 22 story was based on. For more on the retraction, please click here.
ORIGINAL STORY: Antimalaria drugs that U.S. President Donald Trump has touted for treatment of Covid-19 were linked to an increased risk of death and heart ailments in a study.